TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

Benzinga Logo Benzinga By Vandana Singh
DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

DexCom is facing scrutiny after three additional deaths were reported in FDA's MAUDE database related to its G7 continuous glucose monitor, with at least 13 total deaths since the device's 2023 launch. Two law firms have launched class action lawsuits alleging misleading consumer information about device accuracy.

Insights
AMZN   neutral

Pending earnings report, no definitive sentiment yet


DXCM   negative

Multiple death reports, FDA warning letter, class action lawsuits, and allegations of device inaccuracy significantly damage company's reputation and potential legal/financial risks